These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2475686)

  • 21. Verapamil in antihypertensive treatment of patients on renal replacement therapy--clinical implications and pharmacokinetics.
    Beyerlein C; Csaszar G; Hollmann M; Schumacher A
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S35-7. PubMed ID: 2261942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
    Libretti A; Catalano M
    Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive efficacy of sustained-release verapamil.
    Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
    J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in black patients with hypertension.
    Weir MR; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1991; 13(3):409-16. PubMed ID: 1659495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once a day verapamil in essential hypertension.
    Müller FB; Ha HR; Hotz H; Schmidlin O; Follath F; Bühler FR
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):143S-147S. PubMed ID: 3530298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sustained release verapamil in essential hypertension].
    Yodfat Y; Nusbaum M; Gibor Y
    Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.
    Fuenmayor NT; Faggin BM; Cubeddu LX
    Drugs; 1992; 44 Suppl 1():1-11. PubMed ID: 1283570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effect of verapamil in patients with newly discovered mild to moderate essential hypertension.
    Hedbäck B; Hermann LS
    Acta Med Scand Suppl; 1984; 681():129-35. PubMed ID: 6587751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J; Zilles P; Compagnone D
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg.
    Böhmer F; Barousch R; Reinfrank J
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S45-6. PubMed ID: 2475685
    [No Abstract]   [Full Text] [Related]  

  • 33. Short- and long-term treatment of mild to moderate hypertension with verapamil.
    Wicker P; Roudaut R; Gosse P; Dallocchio M
    Am J Cardiol; 1986 Feb; 57(7):83D-86D. PubMed ID: 3953430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Savi L; Guardigli R; Mores N; Folli G
    Eur J Clin Pharmacol; 1988; 34(6):549-53. PubMed ID: 3169108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.
    Caruana M; Heber M; Brigden G; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):549-53. PubMed ID: 3653223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil 240 SR versus verapamil 120 SR in arterial hypertension. A randomized double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
    Corea L; Bentivoglio M; Berioli S; Bianchini C; Savino K; Sardina M
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1501-7. PubMed ID: 2081142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of verapamil and captopril in elderly hypertensive subjects: results of a randomized, double-blind, crossover study.
    Bursztyn M; Ghanem J; Kobrin I; Fidel J; Ben-Ishay D
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):84-8. PubMed ID: 7678684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sustained-released verapamil and ambulatory recording of blood pressure in mild to moderate essential hypertension].
    Bernadet P; Suc JM; Durand D; Galey C; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1992 Feb; 41(2):105-12. PubMed ID: 1562157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instant and sustained-release verapamil in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J; Storstein L; Lauve O
    Am J Cardiol; 1986 Feb; 57(7):59D-63D. PubMed ID: 3513516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.